Point-of-Care Testing on a Mobile Medical Unit in Northern Thailand: Screening for Hyperglycemia, Hyperlipidemia, and Thalassemia Trait

Wanvisa Boonlert, Gerald J Kost, Arunya Jiraviriyakul, Surapon Tangvarasittichai

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The Mobile Medical Unit (MMU) facilitates health care delivery for people in rural areas of Thailand by transporting a health care team and small laboratory directly to where they live. The goal of this study was to use the MMU and point-of-care testing to screen for hyperglycemia, hyperlipidemia, and thalassemia trait. We measured glucose, total cholesterol, and triglyceride in serum using photometers on the MMU. Thalassemia trait was diagnosed by osmotic fragility (OF) and dichlorophenol-indophenol (DCIP) tests. We found that 10.7% of people screened had blood glucose higher than 110 mg/dL, and 5% had higher than 125 mg/dL. We found that 17.8% had total cholesterol higher than 250 mg/dL, and 32.0% had higher than 150 mg/dL. Of the samples, 37.5% yielded positive OF and DCIP tests; 20.2%, positive OF test only; 10.8%, positive DCIP only; and 31.5%, both negative. Heterozygous hemoglobin E was identified in 69 (52.7%) and homozygous hemoglobin E in 15 (11.4%) of 131 subjects. The Naresuan University MMU can be used efficiently with point-of-care testing for hyperglycemia, hyperlipidemia, and thalassemia trait screening in public health.

Original languageEnglish (US)
Pages (from-to)164-167
Number of pages4
JournalPlastic Surgical Nursing
Volume5
Issue number4
DOIs
StatePublished - 2005

Fingerprint

2,6-Dichloroindophenol
Osmotic Fragility
Thalassemia
Thailand
Hyperlipidemias
Hemoglobin E
Hyperglycemia
Cholesterol
Patient Care Team
Blood Glucose
Triglycerides
Public Health
Delivery of Health Care
Glucose
Serum
Point-of-Care Testing

Keywords

  • dichlorophenol-indophenol test
  • hemoglobin E
  • hypercholesterolemia
  • hypertriglyceridemia
  • osmotic fragility test
  • rural provinces
  • thalassemia trait

ASJC Scopus subject areas

  • Surgery
  • Medical–Surgical
  • Advanced and Specialized Nursing

Cite this

Point-of-Care Testing on a Mobile Medical Unit in Northern Thailand : Screening for Hyperglycemia, Hyperlipidemia, and Thalassemia Trait. / Boonlert, Wanvisa; Kost, Gerald J; Jiraviriyakul, Arunya; Tangvarasittichai, Surapon.

In: Plastic Surgical Nursing, Vol. 5, No. 4, 2005, p. 164-167.

Research output: Contribution to journalArticle

@article{d208dcd321cb4bdb90a5cb9d2db3c310,
title = "Point-of-Care Testing on a Mobile Medical Unit in Northern Thailand: Screening for Hyperglycemia, Hyperlipidemia, and Thalassemia Trait",
abstract = "The Mobile Medical Unit (MMU) facilitates health care delivery for people in rural areas of Thailand by transporting a health care team and small laboratory directly to where they live. The goal of this study was to use the MMU and point-of-care testing to screen for hyperglycemia, hyperlipidemia, and thalassemia trait. We measured glucose, total cholesterol, and triglyceride in serum using photometers on the MMU. Thalassemia trait was diagnosed by osmotic fragility (OF) and dichlorophenol-indophenol (DCIP) tests. We found that 10.7{\%} of people screened had blood glucose higher than 110 mg/dL, and 5{\%} had higher than 125 mg/dL. We found that 17.8{\%} had total cholesterol higher than 250 mg/dL, and 32.0{\%} had higher than 150 mg/dL. Of the samples, 37.5{\%} yielded positive OF and DCIP tests; 20.2{\%}, positive OF test only; 10.8{\%}, positive DCIP only; and 31.5{\%}, both negative. Heterozygous hemoglobin E was identified in 69 (52.7{\%}) and homozygous hemoglobin E in 15 (11.4{\%}) of 131 subjects. The Naresuan University MMU can be used efficiently with point-of-care testing for hyperglycemia, hyperlipidemia, and thalassemia trait screening in public health.",
keywords = "dichlorophenol-indophenol test, hemoglobin E, hypercholesterolemia, hypertriglyceridemia, osmotic fragility test, rural provinces, thalassemia trait",
author = "Wanvisa Boonlert and Kost, {Gerald J} and Arunya Jiraviriyakul and Surapon Tangvarasittichai",
year = "2005",
doi = "10.1097/01.poc.0000232581.36762.21",
language = "English (US)",
volume = "5",
pages = "164--167",
journal = "Plastic Surgical Nursing",
issn = "0741-5206",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Point-of-Care Testing on a Mobile Medical Unit in Northern Thailand

T2 - Screening for Hyperglycemia, Hyperlipidemia, and Thalassemia Trait

AU - Boonlert, Wanvisa

AU - Kost, Gerald J

AU - Jiraviriyakul, Arunya

AU - Tangvarasittichai, Surapon

PY - 2005

Y1 - 2005

N2 - The Mobile Medical Unit (MMU) facilitates health care delivery for people in rural areas of Thailand by transporting a health care team and small laboratory directly to where they live. The goal of this study was to use the MMU and point-of-care testing to screen for hyperglycemia, hyperlipidemia, and thalassemia trait. We measured glucose, total cholesterol, and triglyceride in serum using photometers on the MMU. Thalassemia trait was diagnosed by osmotic fragility (OF) and dichlorophenol-indophenol (DCIP) tests. We found that 10.7% of people screened had blood glucose higher than 110 mg/dL, and 5% had higher than 125 mg/dL. We found that 17.8% had total cholesterol higher than 250 mg/dL, and 32.0% had higher than 150 mg/dL. Of the samples, 37.5% yielded positive OF and DCIP tests; 20.2%, positive OF test only; 10.8%, positive DCIP only; and 31.5%, both negative. Heterozygous hemoglobin E was identified in 69 (52.7%) and homozygous hemoglobin E in 15 (11.4%) of 131 subjects. The Naresuan University MMU can be used efficiently with point-of-care testing for hyperglycemia, hyperlipidemia, and thalassemia trait screening in public health.

AB - The Mobile Medical Unit (MMU) facilitates health care delivery for people in rural areas of Thailand by transporting a health care team and small laboratory directly to where they live. The goal of this study was to use the MMU and point-of-care testing to screen for hyperglycemia, hyperlipidemia, and thalassemia trait. We measured glucose, total cholesterol, and triglyceride in serum using photometers on the MMU. Thalassemia trait was diagnosed by osmotic fragility (OF) and dichlorophenol-indophenol (DCIP) tests. We found that 10.7% of people screened had blood glucose higher than 110 mg/dL, and 5% had higher than 125 mg/dL. We found that 17.8% had total cholesterol higher than 250 mg/dL, and 32.0% had higher than 150 mg/dL. Of the samples, 37.5% yielded positive OF and DCIP tests; 20.2%, positive OF test only; 10.8%, positive DCIP only; and 31.5%, both negative. Heterozygous hemoglobin E was identified in 69 (52.7%) and homozygous hemoglobin E in 15 (11.4%) of 131 subjects. The Naresuan University MMU can be used efficiently with point-of-care testing for hyperglycemia, hyperlipidemia, and thalassemia trait screening in public health.

KW - dichlorophenol-indophenol test

KW - hemoglobin E

KW - hypercholesterolemia

KW - hypertriglyceridemia

KW - osmotic fragility test

KW - rural provinces

KW - thalassemia trait

UR - http://www.scopus.com/inward/record.url?scp=84991773001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991773001&partnerID=8YFLogxK

U2 - 10.1097/01.poc.0000232581.36762.21

DO - 10.1097/01.poc.0000232581.36762.21

M3 - Article

AN - SCOPUS:84991773001

VL - 5

SP - 164

EP - 167

JO - Plastic Surgical Nursing

JF - Plastic Surgical Nursing

SN - 0741-5206

IS - 4

ER -